ALKERMES PLC
ALKSNASDAQ🏆 #1096 by market capEarnings Oct 28US Equity
$40.80▲ $0.66 (+1.62%)
🌙 After hours$40.80▲ 0.00%Regular close · extended-hours price shownTrack ALKS
Get earnings, price moves & breaking news on Telegram
24h▲ 1.6%
7d▼ 5.7%
14d▼ 11.4%
30d▼ 14.0%
ytd▲ 45.9%
1y▲ 40.5%
🏦Market Cap
$6.84B
Small Cap
📈Revenue Growth (YoY)
-5.3%
Declining
📊Gross Margin
84.6%
High
💵FCF Margin
13.3%
Healthy
⚖️P/S Ratio
4.1x
Fair
Otter Score
68
Fair
ALKERMES PLC
ALKSAnalyst Ratings
Price
$40.80
Total
29
Raised
1
Lowered
7
Avg PT
$58.83
H / L
$65 / $50
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-09-22 | $56.00 | +37.30% |
Baird | Reiterated | Outperform | 2026-09-22 | — | — |
Needham | Reiterated | Buy | 2026-09-21 | $54.00 | +32.40% |
JP Morgan | Reiterated | Neutral | 2026-07-29 | $29.00 | −28.90% |
Piper Sandler | Reiterated | Overweight | 2026-07-28 | $65.00 | +59.30% |
Stifel | Reiterated | Buy | 2026-07-20 | — | — |
Mizuho | Reiterated | Outperform | 2026-07-02 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-06-29 | $44.00 | +7.80% |
B of A Securities | Downgraded | Neutral → Underperform | 2026-06-29 | — | — |
TD Cowen | Reiterated | Buy | 2026-06-22 | — | — |
UBS | Reiterated | Buy | 2026-05-06 | $42.00 | +2.90% |
Truist Securities | Reiterated | Buy | 2025-11-17 | — | — |
Deutsche Bank | Reiterated | Buy | 2025-11-13 | — | — |
HC Wainwright & Co. | Reiterated | Neutral | 2025-09-09 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-02-14 | $50.00 | +22.50% |
Cantor Fitzgerald | Reiterated | Overweight | 2024-10-25 | — | — |
Jefferies | Reiterated | Buy | 2024-04-09 | $56.00 | +37.30% |
Evercore ISI Group | Upgraded | In Line → Outperform | 2023-10-24 | — | — |
SVB Leerink | Reiterated | Market Perform | 2022-04-28 | — | — |
Citigroup | Reiterated | Neutral | 2022-03-22 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2020-04-02 | — | — |
H.C. Wainwright | Reiterated | Neutral | 2020-02-14 | $43.00 | +5.40% |
Credit Suisse | Downgraded | Outperform → Underperform | 2018-12-13 | — | — |
Bank of America | Reiterated | Buy | 2018-07-27 | — | — |
Barclays | Downgraded | Overweight → Equal Weight | 2017-10-16 | — | — |
Leerink Swann | Downgraded | Outperform → Market Perform | 2017-06-13 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2016-07-26 | — | — |
MKM Partners | Downgraded | Neutral → Sell | 2013-05-24 | — | — |
Lazard | Downgraded | Buy → Neutral | 2013-04-22 | — | — |
Institution
RBC Capital
Reiterated · Outperform · 2026-09-22
$56.00
+37.30%
Baird
Reiterated · Outperform · 2026-09-22
—
—
Needham
Reiterated · Buy · 2026-09-21
$54.00
+32.40%
JP Morgan
Reiterated · Neutral · 2026-07-29
$29.00
−28.90%
Piper Sandler
Reiterated · Overweight · 2026-07-28
$65.00
+59.30%
Stifel
Reiterated · Buy · 2026-07-20
—
—
Mizuho
Reiterated · Outperform · 2026-07-02
—
—
Wells Fargo
Reiterated · Overweight · 2026-06-29
$44.00
+7.80%
B of A Securities
Downgraded · Neutral → Underperform · 2026-06-29
—
—
TD Cowen
Reiterated · Buy · 2026-06-22
—
—
UBS
Reiterated · Buy · 2026-05-06
$42.00
+2.90%
Truist Securities
Reiterated · Buy · 2025-11-17
—
—
Deutsche Bank
Reiterated · Buy · 2025-11-13
—
—
HC Wainwright & Co.
Reiterated · Neutral · 2025-09-09
—
—
Goldman Sachs
Reiterated · Buy · 2025-02-14
$50.00
+22.50%
Cantor Fitzgerald
Reiterated · Overweight · 2024-10-25
—
—
Jefferies
Reiterated · Buy · 2024-04-09
$56.00
+37.30%
Evercore ISI Group
Upgraded · In Line → Outperform · 2023-10-24
—
—
SVB Leerink
Reiterated · Market Perform · 2022-04-28
—
—
Citigroup
Reiterated · Neutral · 2022-03-22
—
—
Morgan Stanley
Reiterated · Equal Weight · 2020-04-02
—
—
H.C. Wainwright
Reiterated · Neutral · 2020-02-14
$43.00
+5.40%
Credit Suisse
Downgraded · Outperform → Underperform · 2018-12-13
—
—
Bank of America
Reiterated · Buy · 2018-07-27
—
—
Barclays
Downgraded · Overweight → Equal Weight · 2017-10-16
—
—
Leerink Swann
Downgraded · Outperform → Market Perform · 2017-06-13
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2016-07-26
—
—
MKM Partners
Downgraded · Neutral → Sell · 2013-05-24
—
—
Lazard
Downgraded · Buy → Neutral · 2013-04-22
—
—
One row per institution · price target from the firm's latest published target